Pfizer and BioNTech seeking emergency use authorization from FDA for Covid-19 vaccine for children younger than 5
CNN
Pfizer and BioNTech are requesting emergency use authorization for their two-dose Covid-19 vaccine for children age 6 months up to 5 years, the companies said Tuesday.
The Pfizer/BioNTech vaccine is already authorized for use in people as young as 5 and would be the first Covid-19 vaccine available for the youngest children. The companies are continuing to test a three-dose version of the vaccine in this younger age group.
In December, Pfizer extended its vaccine in trial in younger children after two child-sized doses of the vaccine did not produce the expected immunity in 2- to 5-year-olds, although it did so for the babies up to age 2.
After recent burglaries at homes of professional athletes – including Kansas City Chiefs stars Patrick Mahomes and Travis Kelce – the NFL and NBA have issued security memos to teams and players warning that “organized and skilled groups” are increasingly targeting players’ residences for such crimes.